Clinical trials
Ischemic Stroke trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 14 |
| Terminated | 7 |
| Active, not recruiting | 4 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroscience Trials Australia | 6 |
| University of Melbourne | 5 |
| The George Institute | 4 |
| The Florey Institute of Neuroscience and Mental Health | 3 |
| Basking Biosciences, Inc. | 2 |
| Bayer | 2 |
| Biotronik SE & Co. KG | 2 |
| Melbourne Health | 2 |
| University of Calgary | 2 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 58 |
| Stroke | 27 |
| Cerebrovascular Disorders | 6 |
| Brain Diseases | 4 |
| Cardiovascular Diseases | 4 |
| Central Nervous System Diseases | 4 |
| Cerebral Hemorrhage | 4 |
| Ischemia | 4 |
| Atrial Fibrillation | 3 |
| Hemorrhagic Stroke | 3 |
Trials
Showing 51 to 58 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.